Evaluates nitrosyl complexes' photoresponse in solvent systems, suggesting new applications in phototherapy.
A set of new coordination compounds of the formula [RuNO(L)Cl3], with L representing the bidentate ligands bipyrimidine (bpym), bipyridine (bpy), or phenanthroline (phen), was prepared and fully characterized. For the isomeric species fac-[RuNO(bpym)Cl3] (1), fac-[RuNO(phen)Cl3] (2), mer-[RuNO(phen)Cl3] (3), fac-[RuNO(bpy)Cl3] (4), and mer-[RuNO(bpy)Cl3] (5), an evaluation of the photoresponse in DMSO was performed under excitation with 450 nm using a continuous-flow arrangement that enabled the simultaneous acquisition of IR and UV-Vis spectral data. Quantum yields for photoinduced release of NO were determined as follows: 5.4 ± 0.5% for fac-[RuNO(bpym)Cl3] (1); 0.8 ± 0.1% for fac-[RuNO(phen)Cl3] (2); 0.6 ± 0.1% for mer-[RuNO(phen)Cl3] (3); 3.7 ± 0.1% for fac-[RuNO(bpy)Cl3] (4); 2.1 ± 0.1% for mer-[RuNO(bpy)Cl3] (5). The product of the photolysis of compound 5 in acetonitrile solution was isolated and structurally characterized as mer-[Ru(CH3CN)(bpy)Cl3] (6). Taking into account the presence of typical DNA intercalating ligands, the complexes can be potentially exploited as photoNORMs.
No takes yet. Share an insight, caveat, or question.
Brovko et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: